NEURALINK SEES $1 BILLION OF REVENUE BY 2031 IN VAST EXPANSION

Summary from the TLDR newsletter

Neuralink expects to put its chips in 20,000 people a year and generate at least $1 billion in annual revenue by 2031. It plans to have about five large clinics in operation and at least three versions of its device available. The company's figures assume a conservative reimbursement of $50,000 per surgery. Several other brain companies are building and testing similar devices. No brain-computer interfaces have yet been commercially approved for permanent implantation by the US FDA - Neuralink expects to gain regulatory approval in the US for its first device by 2029.